Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin DR PK/PD in T2DM
NCT01677299Phase 2Completed
- Sponsor
- Elcelyx Therapeutics
- Start
- May 2012
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ANJ900 in type 2 diabetes mellitus (T2DM), sponsored by Elcelyx Therapeutics. Started May 2012; status: completed.
02
Drugs
ANJ900
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01677299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677299.